BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 9048625)

  • 1. 17-beta-estradiol-dependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo.
    Visser-Wisselaar HA; Van Uffelen CJ; Van Koetsveld PM; Lichtenauer-Kaligis EG; Waaijers AM; Uitterlinden P; Mooy DM; Lamberts SW; Hofland LJ
    Endocrinology; 1997 Mar; 138(3):1180-9. PubMed ID: 9048625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor manipulation.
    Visser-Wisselaar HA; Hofland LJ; van Uffelen CJ; van Koetsveld PM; Lamberts SW
    Digestion; 1996; 57 Suppl 1():7-10. PubMed ID: 8813458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
    Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW
    Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures.
    Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J
    Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
    Lamberts SW; van Koetsveld P; Verleun T
    Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells.
    Xu Y; Song J; Berelowitz M; Bruno JF
    Endocrinology; 1996 Dec; 137(12):5634-40. PubMed ID: 8940394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
    Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
    Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the mechanism of the inhibitory actions of catecholestrogens, tamoxifen and high concentrations of estrogens on prolactin release by cultured rat pituitary tumor cells.
    Lamberts SW; Verleun T
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1117-23. PubMed ID: 2820746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
    Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
    J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
    Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography.
    Schaer JC; Waser B; Mengod G; Reubi JC
    Int J Cancer; 1997 Mar; 70(5):530-7. PubMed ID: 9052751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17 beta-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells.
    Kimura N; Hayafuji C; Konagaya H; Takahashi K
    Endocrinology; 1986 Sep; 119(3):1028-36. PubMed ID: 2874016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary somatostatin receptor (sst)1-5 expression during rat development: age-dependent expression of sst2.
    Reed DK; Korytko AI; Hipkin RW; Wehrenberg WB; Schonbrunn A; Cuttler L
    Endocrinology; 1999 Oct; 140(10):4739-44. PubMed ID: 10499533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of galanin gene expression in the rat anterior pituitary gland by the somatostatin analog SMS 201-995.
    Hyde JF; Howard G
    Endocrinology; 1992 Nov; 131(5):2097-102. PubMed ID: 1385097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone regulates somatostatin receptor subtype messenger ribonucleic acid expression in rat pituitary GH4C1 cells.
    Xu Y; Berelowitz M; Bruno JF
    Endocrinology; 1995 Nov; 136(11):5070-5. PubMed ID: 7588243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries.
    Kimura N; Tomizawa S; Arai KN; Kimura N
    Endocrinology; 1998 Apr; 139(4):1573-80. PubMed ID: 9528936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.
    Reubi JC; Schär JC; Waser B; Wenger S; Heppeler A; Schmitt JS; Mäcke HR
    Eur J Nucl Med; 2000 Mar; 27(3):273-82. PubMed ID: 10774879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percoll density gradient centrifugation of rat pituitary tumor cells: a study of functional heterogeneity within and between tumors with respect to growth rates, prolactin production and responsiveness to the somatostatin analog SMS 201-995.
    Hofland LJ; van Koetsveld PM; Lamberts SW
    Eur J Cancer; 1990 Jan; 26(1):37-44. PubMed ID: 2138476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery.
    Fehlmann D; Langenegger D; Schuepbach E; Siehler S; Feuerbach D; Hoyer D
    J Physiol Paris; 2000; 94(3-4):265-81. PubMed ID: 11088004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.